Close Menu

More articles about Mass Spec

The collaborations center on targeted single-reaction monitoring-based workflows that Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry Center has been developing to allow rapid development of mass spec-based assays and cross-validation of biomarkers across different laboratories.

Thermo has expanded its collaboration with university partners, including George Mason's Lance Liotta and Emanuel Petricoin, to verify and validate protein biomarkers for cancer and other diseases.

The companies will offer the Cerno software with Shimadzu's LCMS instruments for data handling, analysis, and management.

The school has used NSF funding to create a Center of Excellence for proteomics with Agilent's instruments and software.

The firms will combine their mass spec and NMR technologies for metabolomic applications.

AB Sciex plans to introduce later this year a new mass spec platform that combines qualitative and quantitative analysis.

The exclusive agreement covers the RapidFire systems and screening.

PerkinElmer has purchased the ICP-MS joint venture from Danaher that was at the center of PerkinElmer's earlier legal action against MDS.

The separations products company plans to buy the mass spec analysis software maker for at least $3 million.

The acquisition provides AB Sciex with entry into the liquid chromatography market and provides complementary products for its mass spectrometry portfolio.

The ARRA-funded research seeks molecular controls for cancer cells' metabolic changes that enable them to survive stress.

Four AB Sciex 4000 QTraps will be used to test for stimulants, masking agents, glucocortisteroids, and insulin.

Thermo will use the ABPP technology in proteomics tools that it will market and sell worldwide.

Danaher has closed the acquisition, and the mass spec operations will operate under the name AB Sciex. MDS plans to return the majority of proceeds from the sale to shareholders through a share buyback.

PerkinElmer withdrew the patent infringement suit only a week after filing it.

The agreement settles a suit brought in Canada last month by PerkinElmer against MDS, seeking to block the transfer of a joint venture with MDS Analytical Technologies to Danaher.

The suit relates to mass spectrometry patents held by PerkinElmer and comes a month after the firm filed a separate action against MDS in Canada.

Officials from the company said Thermo Fisher's R&D investments would target mass spectrometry, specialty diagnostics, and bioscience reagents.

The triple-quadrupole spectrometer will be used by a 28-member collaborative group around New York.

The revenue from the stimulus orders surpasses a $50 million estimate provided by the firm just a few months ago.


The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.